Photo taken from Nick Vitanza/X
Dec 10, 2023, 17:48
Nick Vitanza: It’s been a dream to bring better treatments to kids with DIPG and CNS tumors
Nick Vitanza, the Director of the Vitanza Lab at the Ben Towne Center for Childhood Cancer Research, posted on X/Twitter:
“It’s been a dream to bring better treatments to kids with DIPG and CNS tumors. It’s thrilling to announce BrainChild Bio a kids first biotech advancing CAR-T cells for CNS tumors (CEO Steve Brugger; CSO Mike Jensen, MD) in partnership with Seattle Children’s Hospital.”
Read more here.
Source: Nick Vitanza/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14